Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid) contains a reactive aldehyde functionality that allows covalent interaction with nucleophilic targets. Its structure makes it a powerful tool in protease mechanism studies and transition-state modeling. The peptide's controlled reactivity enables detailed examination of enzymatic cleavage pathways. Its stability and versatility support diverse biochemical research applications.
CAT No: C11055
CAS No:184179-08-6
Synonyms/Alias:Ac-DEVD-CHO;169332-60-9;184179-08-6;N-acetyl-asp-glu-val-asp-al;AC-ASP-GLU-VAL-ASP-H;Caspase-3 Inhibitor I;(4S,7S,10S,13S)-7-(2-carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oic acid;Ac-Asp-Glu-Val-Asp-Aldehyde;CHEMBL417149;CHEBI:59385;(4S)-4-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-carboxy-3-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid;Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid);L-Valinamide,N-acetyl-L-a-aspartyl-L-a-glutamyl-N-(2-carboxy-1-formylethyl)-;acetyl-Asp-Glu-Val-Asp aldehyde;acetyl-Asp-Glu-Val-Asp-aldehyde;N-acetyl-Asp-Glu-Val-Asp aldehyde;N-acetyl-Asp-Glu-Val-Asp-aldehyde;acetyl-aspartyl-glutamyl-valyl-aspartal;C20H30N4O11;MF 191;2h5i;Ac-Asp-Glu-Val-Asp aldehyde;GTPL6527;SCHEMBL1674857;BDBM10246;DTXSID40937624;UMBVAPCONCILTL-MRHIQRDNSA-N;HY-P1001;s7901;AKOS037648768;CCG-269708;CS-7676;NCGC00345452-02;(4S)-4-[[(2S)-2-acetamido-4-hydroxy-4-oxobutanoyl]amino]-5-[[(2S)-1-[[(2S)-4-hydroxy-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid;AC-29039;BS-15530;DA-60711;FA108687;D71136;Caspase-3 Inhibitor I - CAS 169332-60-9;L 761191;Q27074145;Z4561822377;L-valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-;N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-valinamide;(4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(3S)-3-acetamido-3-formamidopropanoic acid]butanoic acid;(4S,7S,10S,13S)-7-(2-carboxyethyl)-4-(carboxymethyl)-13-formyl-10-isopropyl-2,5,8,11-tetraoxo-3,6,9,12-tetraazapentadecan-15-oicacid;7-(2-Carboxyethyl)-4-(carboxymethyl)-13-formyl-2,5,8,11-tetrahydroxy-10-(propan-2-yl)-3,6,9,12-tetraazapentadeca-2,5,8,11-tetraen-15-oic acid;L-Valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-(2-carboxy-1-formylethyl)-, (S)-;L-Valinamide, N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]- (9CI);N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-valinamide;
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More